We also note that our study includes more recent data through 2015 that may reflect changes in the international CKD-MBD clinical practice guidelines for SHPT management published in 2009 that liberalized the upper maintenance range for PTH [7, 26]. The gene discussed is PTH; the disease is chronic kidney disease.